Patricia S. Steeg

National Cancer Institute — United States

Medicine · Health Sciences

86h-index32.7kcitations589works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Brain Metastases and Treatment(189), Mechanisms of cancer metastasis(167), Cancer Mechanisms and Therapy(65), Lung Cancer Research Studies(51), Ferrocene Chemistry and Applications(51)

Publications589 total

Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems
Neuro-Oncology·2026
Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2025Open Access
Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2025Open Access
Figure S2 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Supplementary Data 1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S3 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S4 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Proteogenomic characterization of invasive breast tumors in young women
npj Breast Cancer·2025· 3 citedOpen Access
A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models
Clinical & Experimental Metastasis·2025· 3 citedOpen Access
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health
The Lancet Oncology·2024· 2 citedOpen Access
108 (PB096): Targeting brain metastasis from triple-negative breast cancer by blocking CSF1R signaling in the tumor microenvironment
European Journal of Cancer·2024
Data from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
2024Open Access
BSLM-11 ESTABLISHING AND VALIDATING IN VIVO MODELS FOR LEPTOMENINGEAL METASTASES IN BREAST CANCER: INSIGHTS AND THERAPEUTIC IMPLICATIONS
Neuro-Oncology Advances·2024Open Access
page 1 of 30Next →

Frequent Co-authors

Diane Palmieri(14), Paul R. Lockman(6), Quentin R. Smith(6), Julie L. Bronder(6), Brunilde Gril(5), Helen R. Thorsheim(5), Robert J. Weil(5), Seth M. Steinberg(5), Emily Hua(5), David J. Liewehr(4), Rajendar K. Mittapalli(4), Kunal S. Taskar(4), Vinay Rudraraju(4), Joost J. Oppenheim(4), Andreas M. Stark(4), Maria J. Merino(4), Eleazar Vega-Valle(4), Kenneth Aldape(3), Julie A. Gaasch(3), Howard M. Johnson(3)